BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 192477)

  • 1. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
    Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
    Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on viomycin IX. Amino acid derivatives on viomycin.
    Kitagawa T; Miura T; Takaishi C; Taniyama H
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on viomycin. VII. Oxidative modifications of viomycin.
    Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
    Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbon-13 nuclear magnetic resonance studies on a new antitubercular peptide antibiotic LL-BM547beta.
    McGahren WJ; Morton GO; Kunstmann MP; Ellestad GA
    J Org Chem; 1977 Apr; 42(8):1282-6. PubMed ID: 191583
    [No Abstract]   [Full Text] [Related]  

  • 5. The structure of the guanido amino acid moiety of viomycin.
    Takita T; Maeda K
    J Antibiot (Tokyo); 1968 Aug; 21(8):512-6. PubMed ID: 4303539
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B).
    Noda T; Take T; Nagata A; Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1972 Jul; 25(7):427-8. PubMed ID: 4350196
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative aspects of hydrogen-deuterium exchange in the 1H, 13C, and 15N nuclear magnetic resonance spectra of viomycin in aqueous solution.
    Hawkes GE; Randall EW; Hull WE; Gattegno D; Conti F
    Biochemistry; 1978 Sep; 17(19):3986-92. PubMed ID: 213101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme immunoassay of viomycin. New cross-linking reagent for enzyme labelling and a preparation method for antiserum to viomycin.
    Kitagawa T; Fujitake T; Taniyama H; Aikawa T
    J Biochem; 1978 May; 83(5):1493-501. PubMed ID: 207686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic hydrogenation of viomycin and capreomycin.
    Dyer JR; Carter JH; van Wyk PJ
    J Med Chem; 1971 Nov; 14(11):1120-1. PubMed ID: 4329900
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of cyclic structure and dehydro-form amino acid residue in a peptide antibiotic.
    Kitagawa T; Miura T; Taniyama H
    J Biochem; 1977 Jun; 81(6):1759-67. PubMed ID: 197067
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical tests of viomycin-pantothenatesulfate (vionactan-P)].
    ARNOLD M
    Schweiz Z Tuberc Pneumonol; 1958; 15(4):203-10. PubMed ID: 13602779
    [No Abstract]   [Full Text] [Related]  

  • 12. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis].
    KUNTZ E
    Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorimetric determination of viomycin.
    JACKSON AW
    Antibiot Chemother (Northfield); 1954 Dec; 4(12):1210-5. PubMed ID: 24543314
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies in vitro with viomycin panthothenate].
    COLOMBI GC; BASILICO F; TROTTA E
    G Ital Della Tuberc; 1958; 12(4):197-201. PubMed ID: 13574580
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
    Kitagawa T; Miura T; Takaishi M; Taniyama H
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
    [No Abstract]   [Full Text] [Related]  

  • 16. [13C-nuclear magnetic resonance of nitro compounds and triazenes produced by decomposition of trisubstituted nitrosoureas].
    Sueyoshi S; Tanno M
    Eisei Shikenjo Hokoku; 1984; (102):108-12. PubMed ID: 6532492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of primary tuberculous infection with viomycin pantothenate].
    SIMON K
    Pediatrie; 1958; 13(4):455-8. PubMed ID: 13600934
    [No Abstract]   [Full Text] [Related]  

  • 18. [Two years of experience with viomycin pantothenate-sulfate (vionactan) in the treatment of pulmonary tuberculosis].
    SCALFI GF; PONTIGGIA P; ROSSA G
    Minerva Med; 1958 Sep; 49(71):3343-56. PubMed ID: 13600139
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental and clinical importance of pantothenates of streptomycin, dihydrostreptomycin and viomycin].
    PREZIOSI P
    Riforma Med; 1958 Aug; 72(33):931-3. PubMed ID: 13579974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Streptomycin, dihydrostreptomycin, neomycin & viomycin pantothenates].
    KELLER H
    G Ital Chemioter; 1957; 4(1-2):33-57. PubMed ID: 13562573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.